Adaptive Biotechnologies Corporation · FWB:1HM

Adaptive Biotechnologies Corporation financial statements

Adaptive Biotechnologies Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue277.0M179.0M170.3M185.3M154.3M98.4M85.1M55.7M38.4M
Cost of revenue71.4M72.1M75.6M57.9M49.3M22.5M22.3M19.7M15.7M
Gross profit205.6M106.9M94.7M127.4M105.0M75.9M62.8M36.0M22.8M
Research and development93.8M103.0M122.1M141.8M142.3M116.1M70.7M39.2M32.0M
Selling, general and administrative72.7M72.8M83.9M88.5M74.5M49.5M30.3M20.4M15.9M
Operating income-57.1M-162.5M-227.0M-200.2M-209.0M-152.8M-78.4M-49.8M-44.5M
Depreciation and amortization16.0M17.4M19.6M20.9M12.3M6.77M6.09M4.30M4.10M
EBITDA-41.1M-145.1M-207.4M-179.3M-196.7M-146.0M-72.3M-45.5M-40.4M
Interest expense11.8M11.6M13.8M4.24M1.67M0000
Income before tax-59.5M-159.6M-225.3M-200.4M-207.3M-146.2M-68.6M-46.4M-42.8M
Income tax000-57.9M-1.69M-6.59M03.31M-804.0K
Net income-59.5M-159.5M-225.3M-200.2M-207.3M-146.2M-68.6M-46.4M-42.8M
Earnings per share, basic-0.39-1.08-1.56-1.40-1.48-1.11-1.01-3.67-3.50
Earnings per share, diluted-0.39-1.08-1.56-1.40-1.48-1.11-1.01-3.67-3.50

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents70.5M47.9M65.1M90.0M139.1M123.4M96.6M55.0M85.3M
Short-term investments156.5M174.4M281.3M408.2M214.0M564.8M480.3M110.0M106.8M
Receivables50.4M41.7M38.0M40.1M17.4M10.0M12.7M4.81M5.58M
Inventory9.82M8.44M14.4M14.5M19.3M14.1M9.07M7.84M4.79M
Current assets300.2M283.8M410.2M562.1M402.7M726.9M612.7M180.7M205.2M
Property, plant and equipment34.1M48.6M68.2M83.4M85.3M39.7M60.4M19.1M14.0M
Goodwill119.0M119.0M119.0M119.0M119.0M119.0M119.0M119.0M119.0M
Total assets512.7M539.4M661.1M856.6M923.3M1.12B912.3M332.7M362.5M
Accounts payable6.47M7.26M7.72M8.08M3.31M3.24M4.45M1.79M1.96M
Current liabilities89.9M98.1M88.0M109.8M113.8M105.2M78.3M22.8M21.0M
Long-term debt126.6M132.4M130.7M125.4M336.0K342.0K
Total debt131.2M133.3M130.7M125.4M111.7M107.9M36.6M561.2M561.7M
Total liabilities287.7M336.9M352.9M392.5M319.2M373.1M341.3M29.9M587.1M
Shareholders' equity218.8M202.7M308.4M464.2M604.0M743.3M571.0M-258.1M-224.6M
Shares outstanding153.8M147.8M145.1M143.1M141.4M137.6M125.2M12.8M139.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-46.0M-95.2M-156.3M-183.9M-192.7M-149.7M205.4M-32.3M-34.9M
Capital spending-2.96M-3.66M-10.7M-16.3M-61.7M-18.8M-11.2M-6.30M-2.42M
Free cash flow-48.9M-98.9M-167.0M-200.3M-254.5M-168.5M194.2M-38.6M-37.3M
Cash from investing38.0M77.8M129.6M2.90M181.2M-117.0M-481.7M736.0K36.4M
Cash from financing30.4M241.0K2.25M132.3M27.1M293.6M319.9M1.25M50.0M
Dividends paid00
Share buybacks7.89M26.7M293.6M324.9M1.27M50.0M
Change in cash22.4M-17.2M-24.4M-48.8M15.6M26.9M43.6M-30.3M51.6M